Check Bicycle Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$479.6M
EPS (TTM)
-4.1827
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.22
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
0EBITDA
-281.1M
Revenue (TTM)
19.3M
Profit Margin
0.00%
Return On Equity TTM
38902000.00%
Track how Bicycle Therapeutics Plc P/E has moved over time to understand its valuation trends.
Bicycle Therapeutics Plc in the last 5 years
Lowest (0.00x)
September 18, 2025
Today (-6.22x)
September 18, 2025
Industry (-3.94x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: -6.22x
Compare market cap, revenue, PE, and other key metrics of Bicycle Therapeutics Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $479.6M | -65.08% | -6.22 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Bicycle Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bicycle Therapeutics Plc investment value today
Current value as on today
₹34,387
Returns
Returns from Bicycle Therapeutics Plc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Bicycle Therapeutics Plc. Average target price of $23.91
Get share price movements and forecasts by analysts on Bicycle Therapeutics Plc.
What analysts predicted
70.01%UPSIDE
Target Price
$23.91
Current Price
$7.17
Analyzed by
18 Analysts
Target
$23.91
Bicycle Therapeutics Plc target price $23.91, a slight upside of 70.01% compared to current price of $7.17. According to 18 analysts rating.
Search interest for Bicycle Therapeutics Plc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 140.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 183.3%
Profit Down
Netprofit is down for the last 6 quarters, -26.54M → -78.95M (in $), with an average decrease of 25.4% per quarter
Price Dip
In the last 1 year, BCYC stock has moved down by -71.6%
Revenue Fall
Revenue is down for the last 2 quarters, 9.97M → 2.92M (in $), with an average decrease of 70.7% per quarter
Organisation | Bicycle Therapeutics Plc |
Headquarters | Portway Building, Cambridge, United Kingdom, CB21 6GS |
Industry | Biotechnology |
CEO | Dr. Kevin Lee M.B.A., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Prof. Michael Charles-Ferguson Hannay | Chief Product & Supply Chain Officer |
Dr. Christian Heinis | Scientific Founder |
Ms. Stephanie Yao | Senior Vice President of Investor Relations and Corporate Communications |
Dr. Kevin Lee M.B.A., Ph.D. | CEO & Executive Director |
Mr. Alistair Milnes | Chief Operating Officer |
Mr. Travis Thompson | Senior VP, Chief Accounting Officer & Principal Accounting Officer |
Dr. Michael Skynner B.sc. Ph.d., Ph.D. | Chief Technology Officer |
Mr. Zafar Qadir | Chief Legal Officer & General Counsel |
Dr. Gillian Langford | Head of Clinical and Project Management |
Ms. Alethia Rene Young | Chief Financial Officer |
Bicycle Therapeutics Plc share price today is $7.17 as on at the close of the market. Bicycle Therapeutics Plc share today touched a day high of $7.23 and a low of $6.96.
Bicycle Therapeutics Plc share touched a 52 week high of $28.67 on and a 52 week low of $6.1 on . Bicycle Therapeutics Plc stock price today i.e. is closed at $7.17,which is 74.99% down from its 52 week high and 17.54% up from its 52 week low.
Bicycle Therapeutics Plc market capitalisation is $0.00T as on .
Indian investors can start investing in Bicycle Therapeutics Plc (BCYC) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Bicycle Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bicycle Therapeutics Plc share’s latest price of $7.17 as on September 19, 2025 at 1:29 am IST, you will get 1.3947 shares of Bicycle Therapeutics Plc. Learn more about
fractional shares .
Bicycle Therapeutics Plc stock has given -65.08% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?